BBI Case Study in International Strategy. Aortyx, a success case in early stage funding for medical device focus in aortic disease


May 31, 2019


Aortyx has closed a seed round this year for the main product that they have in development focused in aortic disease. Jordi Martorell, CEO & Founder along with Patrick Obrien, Lifesciences consultant, and William Hariri, Director at Alira Health, shared with our students the process and the strategy for succeeding in early stage investments

 

During the evening of the BBI Open Day a study case in early stage funding was presented by Jordi Martorell, Patrick O’Brien and William Hariri. The main objective of the evening was to understand how to develop and international strategy for medical devices having Aortyx as an example, and also speak about the experiences of the panelists in order to understand key factors to succeed in fundraising.  

The conversation started with an overview of Aortyx’s main product and how they stablished and developed the licensing agreement to become a start-up.  “One of the main aspects that push us to move forward with Aortyx was the data & and the evidence we had, and the oportunity that was opening for those patient suffering from cardiopathies”, spoke Jordi Martorell.

During this conversation in what is valuable to create a Biotech company, a very precisely point was raised by William Hariri regarding to the importance of a deep analysis and understanding the real unmet need that you are going to address, and decide businesswise if it as well as viable source of business. (continue reading...)

Press Release

Latest news

The Biotechnology Business Institute closes the 5th edition of the Scientific MBA in Lifesciences with a great success and four projects developing drug candidates.

Four drug candidates targeting three indications, Breast Cancer, Chron’s Syndrome and NASH (nonalcoholic steatohepatitis), were presented by our students in the closing ceremony of the Scientific MBA’s as a result of a year developing different intellectual properties for potential new treatments

BBI Case Study in International Strategy. Aortyx, a success case in early stage funding for medical device focus in aortic disease

During the evening of the BBI Open Day a study case in early stage funding was presented by Jordi Martorell, Patrick O’Brien, Lifesciences consultant, and William Hariri, Director at Alira Health. The main objective of the evening was to understand how to develop and international strategy for medical devices.

The Biotechnology Business Institute closes the first BBI Open Day with great success inspiring young scientific professionals

The importance of scientific profiles in a society based in innovation and how their professional development in management can contribute to drug discovery, were some of the main topics presented during the BBI Open Day 2019

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

Filter by category